CN114349961A - CuTCPP @ PDA particle and preparation method and application thereof - Google Patents
CuTCPP @ PDA particle and preparation method and application thereof Download PDFInfo
- Publication number
- CN114349961A CN114349961A CN202111578612.5A CN202111578612A CN114349961A CN 114349961 A CN114349961 A CN 114349961A CN 202111578612 A CN202111578612 A CN 202111578612A CN 114349961 A CN114349961 A CN 114349961A
- Authority
- CN
- China
- Prior art keywords
- cutcpp
- pda
- particles
- preparation
- solvent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Manufacture Of Metal Powder And Suspensions Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a CuTCPP @ PDA particle and a preparation method and application thereof, belonging to the technical field of materials, wherein the preparation method of the CuTCPP @ PDA particle mainly comprises the following steps: adding copper porphyrin (CuTCPP) and Dopamine (DA) into a solvent, stirring and dissolving in the dark at room temperature, then dropwise adding ammonia water with the concentration of 25-28 wt%, continuously stirring for 20-48 hours, centrifugally collecting particles, washing and drying to obtain the CuTCPP @ PDA particles. The invention realizes the doping of copper porphyrin into polydopamine particles in a weak base environment to obtain CuTCPP @ PDA particles with acid response, and the CuTCPP @ PDA particles have wide application prospect in drug transportation and/or drug release; the preparation method is simple and easy to implement, and the raw materials can adopt commercial products, so that the preparation method has wide practical application value.
Description
Technical Field
The invention relates to the technical field of materials, and particularly relates to CuTCPP @ PDA particles and a preparation method and application thereof.
Background
Porphyrins are a class of macrocyclic compounds formed by four pyrrole rings linked by methine bridges. The parent of the porphyrin is a porphine ring (shown as a chemical formula (a), protoporphyrin HTCPP), and a compound formed by replacing hydrogen atoms on four meso-position carbons (5, 10, 15, 20) and eight beta-position carbons (2, 3, 7, 8, 12, 13, 17, 18) on the ring by other substituents is porphyrin (shown as a chemical formula (b)); four nitrogen atoms at the center of the porphyrin ring can coordinate with metal ions, so that stable metalloporphyrin compounds (shown as chemical formula (c)) such as copper porphyrin (copper (II) tetracarboxyphenyl porphyrin, CuTCPP) and the like are formed.
Polydopamine (PDA) is a eumelanin-like substance synthesized by oxidizing dopamine hydrochloride, and the surface of a Polydopamine nanomaterial contains many functional groups, such as catechol, amine, imine, and the like, which provide covalent bonding sites for other materials.
At present, no research report of CuTCPP @ PDA particles, and a preparation method and application thereof is found in the prior art.
Disclosure of Invention
Aiming at the defects, the invention aims to provide the CuTCPP @ PDA particle and the preparation method and application thereof.
In order to achieve the purpose, the invention adopts the following technical scheme:
the invention provides a preparation method of CuTCPP @ PDA particles, which comprises the following steps: adding copper porphyrin (CuTCPP) and Dopamine (DA) into a solvent, stirring and dissolving in the dark at room temperature, then dropwise adding ammonia water with the concentration of 25-28 wt%, continuously stirring for 20-48 hours, centrifugally collecting particles, washing and drying to obtain CuTCPP @ PDA particles; wherein the mass ratio of copper porphyrin to dopamine is 5-10: 280-320; the mass-volume ratio of the copper porphyrin to the ammonia water is 5-10: 0.2-1.
Further, the mass ratio of the copper porphyrin to the dopamine is preferably 6-8: 290-310; more preferably 7.8: 300.
Further, the mass-to-volume ratio (mg/mL) of the copper porphyrin to the ammonia water is 6-8: 0.2-0.5; more preferably 7.8: 0.3.
Further, the solvent is one or two of deionized water and ethanol; preferably, the solvent is a mixed solvent consisting of ethanol and deionized water in a volume ratio of 3-5: 7-12; more preferably a mixed solvent consisting of ethanol and deionized water in a volume ratio of 4: 9.
The invention also provides the CuTCPP @ PDA particle prepared by the preparation method.
The invention also provides application of the CuTCPP @ PDA particles in drug transportation and/or drug release.
The invention also provides a drug transport carrier, which comprises the CuTCPP @ PDA particles.
In summary, the invention has the following advantages:
1. the CuTCPP @ PDA particle can be decomposed under an acidic condition, has excellent pH response behavior, infrared driving performance and a function of catalytically releasing nitric oxide, and has a wide application prospect in drug transportation and/or drug release.
2. The principle of the CuTCPP @ PDA particles of the present invention, which are decomposable under acidic conditions, having excellent pH response behavior, is as follows (as shown in fig. 1): porphyrins tend to aggregate in one-dimensional direction, polydopamine carries cationic charge due to partial protonation under acidic or neutral conditions, and porphyrin molecules with negative charges are assembled into a large number of J-aggregates through electrostatic interaction; under alkaline conditions, these polydopamine cations almost disappear, and there is no direct interaction force allowing the Tetracarboxylporphyrin (TCPP) molecules to assemble into a sufficient amount of J-aggregates. The J-aggregates, however, can be regenerated by protonation of the polydopamine, so that the CuTCPP @ PDA particles will decompose under acidic conditions.
3. The invention realizes the doping of copper porphyrin into polydopamine particles in a weak base environment to obtain CuTCPP @ PDA particles with acid response.
Drawings
FIG. 1 is a schematic diagram of the CuTCPP @ PDA particles of the present invention having an acid response;
FIG. 2 is an SEM image of a PDA particle, HTCPP @ PDA particle, and CuTCPP @ PDA particle of the present invention;
FIG. 3 is an EDS energy spectrum of CuTCPP @ PDA particles of the present invention;
FIG. 4 is a graph showing the results of a fluorescence response test of HTCPP @ PDA particles of the present invention;
FIG. 5 is a graph showing the results of dissolution testing of CuTCPP @ PDA particles in accordance with the present invention;
FIG. 6 is a graph showing the results of infrared driving of the PDA particles and CuTCPP @ PDA particles of the present invention.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the detailed description and specific examples, while indicating the preferred embodiment of the invention, are intended for purposes of illustration only and are not intended to limit the scope of the invention.
Thus, the following detailed description of the embodiments of the present invention is not intended to limit the scope of the invention as claimed, but is merely representative of selected embodiments of the invention. All other embodiments, which can be derived by a person skilled in the art from the embodiments of the present invention without making any creative effort, shall fall within the protection scope of the present invention.
Example 1
This example provides a method for preparing CuTCPP @ PDA particles, comprising the steps of: preparing 78mL of solvent by ethanol and deionized water according to the volume ratio of 4:9, adding 7.8mg of copper porphyrin CuTCPP and 300mg of Dopamine (DA), placing on a stirrer, and stirring at room temperature in a dark place until the solvent is dissolved; then 0.3mL of ammonia water (25 wt%) is added dropwise, and stirring is continued for 24 h; and centrifugally collecting particles at the rotating speed of 10000r/min, washing with deionized water, and drying to obtain CuTCPP @ PDA particles.
Example 2
This example provides a method for making CuTCPP @ PDA particles, which differs from example 1 only in that: the mass of Dopamine (DA) is adjusted to be 315mg, and the mass of copper porphyrin CuTCPP is adjusted to be 6 mg; the rest steps and parameters are the same.
Example 3
This example provides a method for making CuTCPP @ PDA particles, which differs from example 1 only in that: the mass of Dopamine (DA) is adjusted to 285mg, the mass of copper porphyrin CuTCPP is adjusted to 9mg, and the dosage of ammonia water (25 wt%) is adjusted to 0.5 mL; the rest steps and parameters are the same.
Comparative example 1
The embodiment provides a preparation method of PDA particles, which comprises the following steps: preparing 78mL of solvent from ethanol and deionized water in a volume ratio of 4:9, adding 300mg of Dopamine (DA), placing on a stirrer, and stirring at room temperature in a dark place until the solvent is dissolved; 0.3mL of ammonia water (25 wt%) is added dropwise, and stirring is continued for 24 h; and centrifugally collecting particles at the rotating speed of 10000r/min, washing with deionized water, and drying to obtain the PDA particles.
Comparative example 2
This example provides a method of making HTCPP @ PDA particles, comprising the steps of: preparing 78mL of solvent by ethanol and deionized water according to the volume ratio of 4:9, adding 7.8mg of protoporphyrin HTCPP and 300mg of Dopamine (DA), placing on a stirrer, and stirring at room temperature in a dark place until the solvent is dissolved; 0.3mL of ammonia water (25 wt%) is added dropwise, and stirring is continued for 24 h; and centrifugally collecting particles at a rotating speed of 10000r/min, washing with deionized water, and drying to obtain the HTCPP @ PDA particles.
Experimental example 1
In this example, the sample particles obtained in example 1(CuTCPP @ PDA particles), comparative example 1(PDA particles) and comparative example 2(HTCPP @ PDA particles) were subjected to scanning electron microscope photography. SEM results show that the three particles are microspherical in morphology and clear in surface profile of the microsphere, as shown in FIG. 2. The sample particles obtained in example 1 were subjected to EDS analysis using a scanning electron microscope: the presence of PDA and protoporphyrin or copper porphyrin is demonstrated by the EDS spectrum of C, N, O elements, and the presence of copper porphyrin can be confirmed by the EDS spectrum of Cu, which proves the successful incorporation of copper porphyrin into the particles, as shown in FIG. 3.
In this example, unless otherwise specified and specifically described, the experimental procedures and the instruments or reagents used therein may be those according to the conventional methods in the art and commercially available products, and the description thereof is not repeated.
Experimental example 2
In this example, the sample particles obtained in example 1(CuTCPP @ PDA particles), comparative example 1(PDA particles) and comparative example 2(HTCPP @ PDA particles) were placed on a transparent glass plate and photographed by a laser confocal microscope. The particles are irradiated by light sources with excitation wavelengths of 488nm and 561nm respectively, and shooting results show that both the PDA and the CuTCPP @ PDA particles do not have the fluorescence effect, but the HTCPP @ PDA particles have the fluorescence effect, and the test result of the HTCPP @ PDA particles is shown in FIG. 4.
In this example, unless otherwise specified and specifically described, the experimental procedures and the instruments or reagents used therein may be those according to the conventional methods in the art and commercially available products, and the description thereof is not repeated.
Experimental example 3
In this example, the sample particles obtained in example 1(CuTCPP @ PDA particles), comparative example 1(PDA particles) and comparative example 2(HTCPP @ PDA particles) were dissolved in 50% glacial acetic acid, NaOH solution at pH 10 and deionized water, respectively, and only the CuTCPP @ PDA particles were completely dissolved in 50% glacial acetic acid, but the solutions were hardly dissolved in deionized water and NaOH solution at pH 10, while the PDA and HTCPP @ PDA particles were not dissolved in the three solutions, and the test results of the CuTCPP @ PDA particles are shown in FIG. 5.
In this example, unless otherwise specified and specifically described, the experimental procedures and the instruments or reagents used therein may be those according to the conventional methods in the art and commercially available products, and the description thereof is not repeated.
Experimental example 4
In this example, the infrared driving experiment was carried out on the sample particles obtained in example 1(CuTCPP @ PDA particles) and comparative example 1(PDA particles) by the following procedure: dissolving the prepared CuTCPP @ PDA particles and Polydopamine (PDA) particles in RO water, irradiating the solution by using infrared rays, and observing under an optical microscope. As a result: the CuTCPP @ PDA particles retained the infrared drive of the Polydopamine (PDA) particles, and the results of the test are shown in fig. 6.
In this example, unless otherwise specified and specifically described, the experimental procedures and the instruments or reagents used therein may be those according to the conventional methods in the art and commercially available products, and the description thereof is not repeated.
In conclusion, the invention realizes that the copper porphyrin is doped into the polydopamine particles in the weak base environment to obtain the CuTCPP @ PDA particles with acid response, and the CuTCPP @ PDA particles have wide application prospects in drug transportation and/or drug release; the preparation method is simple and easy to implement, and the raw materials can adopt commercial products, so that the preparation method has wide practical application value.
The foregoing is merely exemplary and illustrative of the present invention and it is within the purview of one skilled in the art to modify or supplement the embodiments described or to substitute similar ones without the exercise of inventive faculty, and still fall within the scope of the claims.
Claims (9)
1. A preparation method of CuTCPP @ PDA particles is characterized by comprising the following steps: adding copper porphyrin (CuTCPP) and Dopamine (DA) into a solvent, stirring and dissolving in the dark at room temperature, then dropwise adding ammonia water with the concentration of 25-28 wt%, continuously stirring for 20-48 hours, centrifugally collecting particles, washing and drying to obtain CuTCPP @ PDA particles; wherein the mass ratio of copper porphyrin to dopamine is 5-10: 280-320; the mass-volume ratio of the copper porphyrin to the ammonia water is 5-10: 0.2-1.
2. The method for preparing CuTCPP @ PDA particles as claimed in claim 1, wherein the mass ratio of copper porphyrin to dopamine is 6-8: 290-310.
3. The method of making a CuTCPP @ PDA particle of claim 1 or 2, wherein the mass ratio of copper porphyrin to dopamine is 7.8: 0.3.
4. The method of making CuTCPP @ PDA particles as recited in claim 1, wherein the solvent is one or both of deionized water and ethanol.
5. The method for preparing CuTCPP @ PDA particles as claimed in claim 1 or 4, wherein the solvent is a mixed solvent composed of ethanol and deionized water in a volume ratio of 3-5: 7-12.
6. The method of making CuTCPP @ PDA particles as recited in claim 5, wherein the solvent is a mixed solvent consisting of ethanol and deionized water in a volume ratio of 4: 9.
7. A preparation method of CuTCPP @ PDA particles is characterized by being prepared by the preparation method of the CuTCPP @ PDA particles as described in any one of claims 1-6.
8. Use of the CuTCPP @ PDA particle of claim 7 for drug transport and/or drug release.
9. A drug delivery vehicle comprising the CuTCPP @ PDA particle of claim 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111578612.5A CN114349961B (en) | 2021-12-22 | 2021-12-22 | CuTCPP@PDA particle and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111578612.5A CN114349961B (en) | 2021-12-22 | 2021-12-22 | CuTCPP@PDA particle and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114349961A true CN114349961A (en) | 2022-04-15 |
CN114349961B CN114349961B (en) | 2023-05-30 |
Family
ID=81100445
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202111578612.5A Active CN114349961B (en) | 2021-12-22 | 2021-12-22 | CuTCPP@PDA particle and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114349961B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115382008A (en) * | 2022-09-22 | 2022-11-25 | 西南交通大学 | Preparation method of injectable hydrogel suitable for diabetic wound repair |
CN117186764A (en) * | 2023-03-23 | 2023-12-08 | 南昌师范学院 | Polydopamine/porphyrin coating and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009298731A (en) * | 2008-06-13 | 2009-12-24 | Tokyo Metropolitan Univ | Metalloporphyrin complex for inhibiting oxidative injury and pharmaceutical composition using the same |
US20140336040A1 (en) * | 2012-01-05 | 2014-11-13 | Nanyang Technological University | Methods of preparing monodispersed polydopamine nano- or microspheres, and methods of preparing nano- or microstructures based on the polydopamine nano- or microspheres |
CN109663151A (en) * | 2018-12-19 | 2019-04-23 | 西南交通大学 | A kind of preparation method and application of the rich amino timbering material of tetracarboxylic phenyl porphyrin copper modification and a kind of vascular stent material and application |
CN111643732A (en) * | 2020-06-03 | 2020-09-11 | 西南交通大学 | Preparation method of medical implant material with titanium dioxide metalloporphyrin coating |
CN112442185A (en) * | 2019-09-02 | 2021-03-05 | 天津大学 | Polydopamine-coated zirconium-based metal organic material, preparation method and application thereof |
CN113189070A (en) * | 2021-04-28 | 2021-07-30 | 香港理工大学 | Nano probe, preparation method and application thereof, and detection system for miRNAs of circulating tumor cells |
CN113662925A (en) * | 2021-08-24 | 2021-11-19 | 海南大学 | Polydopamine @ gold composite nanoflower drug-loaded particles and preparation method and application thereof |
-
2021
- 2021-12-22 CN CN202111578612.5A patent/CN114349961B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009298731A (en) * | 2008-06-13 | 2009-12-24 | Tokyo Metropolitan Univ | Metalloporphyrin complex for inhibiting oxidative injury and pharmaceutical composition using the same |
US20140336040A1 (en) * | 2012-01-05 | 2014-11-13 | Nanyang Technological University | Methods of preparing monodispersed polydopamine nano- or microspheres, and methods of preparing nano- or microstructures based on the polydopamine nano- or microspheres |
CN109663151A (en) * | 2018-12-19 | 2019-04-23 | 西南交通大学 | A kind of preparation method and application of the rich amino timbering material of tetracarboxylic phenyl porphyrin copper modification and a kind of vascular stent material and application |
CN112442185A (en) * | 2019-09-02 | 2021-03-05 | 天津大学 | Polydopamine-coated zirconium-based metal organic material, preparation method and application thereof |
CN111643732A (en) * | 2020-06-03 | 2020-09-11 | 西南交通大学 | Preparation method of medical implant material with titanium dioxide metalloporphyrin coating |
CN113189070A (en) * | 2021-04-28 | 2021-07-30 | 香港理工大学 | Nano probe, preparation method and application thereof, and detection system for miRNAs of circulating tumor cells |
CN113662925A (en) * | 2021-08-24 | 2021-11-19 | 海南大学 | Polydopamine @ gold composite nanoflower drug-loaded particles and preparation method and application thereof |
Non-Patent Citations (2)
Title |
---|
ZENG, JY ; WANG, XS: "Universal Porphyrinic Metal-Organic Framework Coating to Various Nanostructures for Functional Integration", 《ACS APPLIED MATERIALS & INTERFACES》 * |
秦玉杰;韩宇;靳杭;高颖;单晓茜;: "具有高光热转化率和环境pH响应的载药硫化铜纳米粒子", 科学通报 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115382008A (en) * | 2022-09-22 | 2022-11-25 | 西南交通大学 | Preparation method of injectable hydrogel suitable for diabetic wound repair |
CN115382008B (en) * | 2022-09-22 | 2023-03-10 | 西南交通大学 | Preparation method of injectable hydrogel suitable for diabetic wound repair |
CN117186764A (en) * | 2023-03-23 | 2023-12-08 | 南昌师范学院 | Polydopamine/porphyrin coating and preparation method thereof |
CN117186764B (en) * | 2023-03-23 | 2024-03-29 | 南昌师范学院 | Polydopamine/porphyrin coating and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN114349961B (en) | 2023-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN114349961A (en) | CuTCPP @ PDA particle and preparation method and application thereof | |
CN108659836B (en) | High-quantum-yield nitrogen-sulfur co-doped fluorescent carbon dot and preparation method and application thereof | |
CN104371727B (en) | Conversion nano granule and preparation method thereof on a kind of water solublity | |
CN108192602A (en) | It is a kind of with room temperature phosphorimetry property without metal-containing polymer carbon dots, preparation method and applications | |
Pu et al. | Artificial Light‐Harvesting Material Based on Self‐Assembly of Coordination Polymer Nanoparticles | |
CN113501776B (en) | Near infrared luminous free radical cation compound and preparation and application thereof | |
CN114574196B (en) | Preparation method and application of carbon quantum dot with high fluorescence quantum yield | |
CN107158379B (en) | Nucleic acid aptamer modified core-shell composite material and preparation method and application thereof | |
CN112641951B (en) | Bioactive supermolecule chiral hydrogel and preparation method and application thereof | |
Pyo et al. | Synthesis and Photophysical Properties of Light‐Harvesting Gold Nanoclusters Fully Functionalized with Antenna Chromophores | |
CN114410299B (en) | Carbon dot and preparation method of carbon dot-based composite material | |
CN111334297A (en) | Nitroaromatic explosive detection film and preparation method and application thereof | |
CN109796965B (en) | Long-life luminescent nanoparticle and preparation method and application thereof | |
CN114015437B (en) | Red light carbon quantum dot and preparation method thereof | |
CN107033513B (en) | A kind of phycocyanin/collagen/carboxylic carbon nano-tube/polyacrylamide composite gel preparation method and application | |
CN113462380B (en) | Organic gel for realizing triplet annihilation photon up-conversion in air state and preparation method and application thereof | |
CN113289669B (en) | Preparation method of beaded carbon nanofiber loaded titanium oxide photocatalyst | |
CN108084451B (en) | Water-soluble fullerene nano material and preparation method and application thereof | |
CN104525259A (en) | Preparation method of polypyrrole/palladium-cellulose paper base catalyst for catalyzing ammonia borane dehydrogenation | |
CN106544017A (en) | A kind of g C3N4/ MF composite construction fluorescent microspheres and preparation method thereof | |
CN111732950B (en) | Azaanthracene derivative TTA-UC weak light up-conversion system and preparation method and application thereof | |
CN115057428A (en) | Hydrophobic near-infrared emission carbon quantum dot and preparation method and application thereof | |
CN111808610A (en) | Carbon nitride-like phosphorus-rich quantum dot fluorescent probe and preparation method and application thereof | |
CN103990438A (en) | Azo dye adsorbent and application thereof | |
CN112452310A (en) | Nitrogen-doped carbon adsorbent, preparation method thereof and application of nitrogen-doped carbon adsorbent to adsorption of organic dye |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |